- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02931409
Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response
Intraoperative PEEP Optimization: Effects on Postoperative Pulmonary Complications and Inflammatory Response. A Double-center, Prospective, Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients undergoing general anesthesia and mechanical ventilation during major abdominal surgery commonly develop pulmonary atelectasis or even hyperdistension of the lungs can occur leading to adverse consequences either intraoperatively or postoperatively. Lung protective ventilation (LPV, PEEP = 6 cmH2O, TV = 6 mL/Kg IBW and regular recruitments) during the intraoperative period can reduce the risk of ventilator induced lung injury (VILI) and prevent the formation of pulmonary atelectasis.
In our investigator-initiated, double-center, single-blinded, prospective, randomized, controlled clinical trial a total number of 40 patients with bladder cancer undergoing open radical cystectomy and urinary diversion (ileal conduit or orthotopic bladder substitute) will be enrolled and randomized into two groups. Standard lung protective mechanical ventilation with the use of 6 cmH2O of PEEP and low tidal volumes (6mL/Kg IBW), a fraction of inspired oxygen (FiO2) of 0.5 and a respiratory rate to maintain an end tidal carbon dioxide (ETCO2) between 35-40 mmHg will be performed in control group, and a strategy of lung protective mechanical ventilation applying an optimal, individual PEEP determined by static pulmonary compliance (Cstat) directed PEEP titration procedure will be performed in study group.
During preoperative assessment, respiratory failure risk index (RFRI) will be recorded and informed consent will be obtained. Regarding to the protocol, a central vein catheter will be placed on the day before surgery, serum procalcitonin (PCT) level will be measured and a chest X-ray examination will be performed.
Before induction of anesthesia, an epidural catheter and an arterial canula for invasive blood pressure monitoring will be inserted. Immediately after induction of anesthesia and orotracheal intubation, all patients will be submitted to an alveolar recruitment maneuver (ARM) using the sustained airway pressure by the CPAP method, applying 30 cmH2O PEEP for 30 seconds. After ARM PEEP will be set to 6 cmH2O in the control group ("standard PEEP") and LPV will be performed. In the study group ("optimal PEEP") PEEP will be set to 14 cmH2O and a Cstat directed decremental PEEP titration procedure will be performed (every 4 minutes PEEP will be decreased by 2 cmH2O, until a final PEEP of 6 cmH2O) to determine the best individual PEEP. During surgery ARM will be repeated and arterial and central vein blood gas samples (ABGs, CVBGs) will be evaluated every 60 minutes. PCT levels will be measured 2, 6, 12, 24, 48 and 72 hours after surgical incision.
After extubation, patients will be addmitted to the Department of Anesthesiology and Intensive Care. ABGs and CVBGs will be collected and evaluated, PaO2/FiO2 and dCO2 will be calculated every 6 hours until 72 hours after surgery. On the first postoperative day chest X-ray will be performed and repeated on the following days if developing of pulmonary complications were suspected. Continuous epidural analgesia will be introduced, and evaluated effective if numeric pain rating scale point would be lower than 3 points.
During postoperative care continuous intraabdominal pressure (IAP) monitoring via a direct intraperitoneal catheter placed before closure of the abdominal wall will be performed to eliminate bias caused by the elevation of intraabdominal pressure.
Patients' clinical progress and secondary endpoints will be monitored by daily SOFA Scores, laboratory and physical examinations.
During follow-up period in-hospital stay, 28-days and in-hospital mortality will also be evaluated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Csongrád
-
Szeged, Csongrád, Hungary, 6722
- University of Szeged, Faculty of Medicine, Department of Anaesthesiology and Intensive Therapy
-
-
Pest
-
Budapest, Pest, Hungary, 1076
- Péterfy Sándor Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with bladder cancer undergoing radical cystectomy and urinary diversion (ileal conduit or orthotopic bladder substitute)
Exclusion Criteria:
- Age < 18 years
- ASA grade IV
- History of severe chronic obstructive pulmonary disease (COPD, GOLD grade III or IV)
- History of severe or uncontrolled bronchial asthma
- History of severe restrictive pulmonary disease
- Pulmonary metastases
- History of any thoracic surgery
- Need for thoracic drainage before surgery
- Renal replacement therapy prior to surgery
- Congestive heart failure (NYHA grade III or IV)
- Extreme obesity (BMI > 35 Kg/m2)
- Lack of patient's consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Optimal PEEP
Patients submitted to general anesthesia and open radical cystectomy and urinary diversion (20 subjects) will be submitted an alveolar recruitment maneuver using the sustained airway pressure by the CPAP method, applying 30 cmH2O PEEP for 30 seconds followed by a decremental PEEP titration procedure directed by static pulmonary compliance (Cstat).
During PEEP titration procedure PEEP will be decreased from 14 cmH2O by 2 cmH2O every 4 minutes, until a final PEEP of 6 cmH2O.
Optimal PEEP is considered as a PEEP value resulting the highest possible Cstat measured by ventilator.
After PEEP titration procedure a lung protective mechanical ventilation will be performed using optimal PEEP and low tidal volumes (6 mL/Kg IBW).
|
Optimal PEEP determined by Cstat during PEEP titration procedure.
|
Active Comparator: Standard PEEP
Patients submitted to general anesthesia and open radical cystectomy and urinary diversion (20 subjects) will be submitted an alveolar recruitment maneuver using the sustained airway pressure by the CPAP method, applying 30 cmH2O PEEP for 30 seconds followed by a standard lung protective mechanical ventilation using a PEEP value of 6 cmH2O and low tidal volumes (6 mL/Kg).
|
Lung protective mechanical ventilation applying a PEEP value of 6 cmH2O
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative Pulmonary Complications
Time Frame: 72 hours
|
New infiltrates or atelectasis on chest X-ray, abnormal breathing sounds on auscultation, excessive bronchial secretions, unexplained fever, respiratory failure defined as PaO2/FiO2 < 300 or need for non-invasive or invasive ventilatory support.
|
72 hours
|
Procalcitonin Kinetics
Time Frame: 72 hours
|
Serum procalcitonin levels during and after surgery.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Circulatory Failure
Time Frame: 28 days
|
Severe hypotension, arrhytmias, decreased cardiac output, severe metabolic acidosis, congestive heart failure, acute coronary syndrome, pulmonary embolism and cardiac arrest.
|
28 days
|
Incidence of Gastrointestinal Dysfunctions
Time Frame: 28 days
|
Constipation or ileus, anastomotic leakage and need for urgent reoperation, disorders of liver function.
|
28 days
|
Incidence of Renal Dysfunction
Time Frame: 28 days
|
RIFLE Criteria
|
28 days
|
Incidence of Hematologic and Coagulation Disorders
Time Frame: 72 hours
|
Severe bleeding and/or coagulopathy
|
72 hours
|
Infection
Time Frame: 28 days
|
Any infections except from pneumonia.
|
28 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ICU days
Time Frame: 28 days
|
Defined as a period from the first postoperative day until emission from the ICU.
|
28 days
|
In-hospital Stay
Time Frame: 28 days
|
From the day of surgery until emission from hospital.
|
28 days
|
Mortality
Time Frame: 28 days
|
In-hospital and 28 days mortality.
|
28 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Zsolt Molnár, Prof, MD, PhD, DEAA, University of Szeged, Faculty of Medicine, Department of Anaesthesiology and Intensive Therapy
- Principal Investigator: Zoltán Ruszkai, MD, Péterfy Sándor Hospital, Department of Anaesthesiology and Intensive Care
Publications and helpful links
General Publications
- Ruszkai Z, Kiss E, Laszlo I, Bokretas GP, Vizseralek D, Vamossy I, Surany E, Buzogany I, Bajory Z, Molnar Z. Effects of intraoperative positive end-expiratory pressure optimization on respiratory mechanics and the inflammatory response: a randomized controlled trial. J Clin Monit Comput. 2021 May;35(3):469-482. doi: 10.1007/s10877-020-00519-6. Epub 2020 May 9.
- Ruszkai Z, Kiss E, Laszlo I, Gyura F, Surany E, Bartha PT, Bokretas GP, Racz E, Buzogany I, Bajory Z, Hajdu E, Molnar Z. Effects of intraoperative PEEP optimization on postoperative pulmonary complications and the inflammatory response: study protocol for a randomized controlled trial. Trials. 2017 Aug 11;18(1):375. doi: 10.1186/s13063-017-2116-z.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 21586-4/2016/EKU
- CO-338-045 (Péterfy Sándor Hospital Scientific Research Ethics Committe)
- 149/2016-SZTE (Other Identifier: University of Szeged Human Investigation Review Board)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Response
-
Virginia Polytechnic Institute and State UniversityRecruitingInflammatory ResponseUnited States
-
Utah State UniversityGreenAcres FoundationRecruitingInflammatory ResponseUnited States
-
Assiut UniversityCompleted
-
Norma Osama Abdalla ZayedAbdelhamid, Bassant Mohamed, M.D.CompletedInflammatory ResponseEgypt
-
University of ViennaRecruiting
-
University of Southern CaliforniaNot yet recruiting
-
Utah State UniversityDuke University; United States Department of Agriculture (USDA)Recruiting
-
Galvani BioelectronicsNAMSACompleted
-
NYU Langone HealthTerminatedInflammatory ResponseUnited States
Clinical Trials on Optimal PEEP
-
Mei-Yun ChangCompletedAcute Respiratory Distress SyndromeTaiwan
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedPulmonary AtelectasisBrazil
-
Fujian Medical University Union HospitalCompleted
-
Fundación para la Investigación del Hospital Clínico...Hospital General Universitario Gregorio Marañon; Germans Trias i Pujol Hospital and other collaboratorsCompletedModerated-high Risk of Postoperative Pulmonary Complication | Abdominal Surgery Expected More Than Two HoursSpain, United States, Argentina, Sweden
-
Seoul National University HospitalCompleted
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Mansoura UniversityRecruitingOne Lung VentilationEgypt
-
University Hospital, AngersNot yet recruiting